Loading
Latest filing published 23 Sept 2022 for GeoVax Labs, Inc., €11k.
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Filings by Randal D. Chase span 2 companies, the busiest being Bioject Medical Technologies Inc and GeoVax Labs, Inc. Between 7 June 2006 and 21 September 2022, the trades on record add up to 16 filings.
On the market, this insider has only ever bought: 9 purchases, €126k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 7 option exercises. 2022 to date brings 2 purchases and no sales.
In size, the median ticket on the buying side is €5,107.
The record was last updated on 23 September 2022 with an open-market purchase (€11k) in GeoVax Labs, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
16 of 16 declarations